Pricing
  1. US-listed companies
  2. SELLAS Life Sciences Group, Inc.
  3. Financials
  4. Return on Assets

SELLAS Life Sciences Group, Inc. (SLS)

Market cap
$552.77M
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-240.8-12.33%
Dec 31, 2023-274.6+57.01%
Dec 31, 2022-174.9+205.61%
Dec 31, 2021-57.2+6.75%
Dec 31, 2020-53.6-53.41%
Dec 31, 2019-115.1+4.90%
Dec 31, 2018-109.7+129.37%
Dec 31, 2017-47.8+50.27%
Dec 31, 2016-31.8-59.49%
Dec 31, 2015-78.6+80.81%
Dec 31, 2014-43.5-59.49%
Dec 31, 2013-107.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat